.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Fuji
Deloitte
Federal Trade Commission
Johnson and Johnson
Argus Health
Queensland Health

Generated: June 22, 2017

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ciprofloxacin hydrochloride and what is the scope of ciprofloxacin hydrochloride patent protection?

Ciprofloxacin hydrochloride
is the generic ingredient in seven branded drugs marketed by Taro Pharm, Mylan, Wraser Pharms, Barr, Carlsbad, Pliva, Apotex Inc, Teva, Bayer Hlthcare, Nostrum Labs, Idt Australia Ltd, Unique Pharm Labs, Depomed Inc, Sun Pharm Inds Ltd, Teligent, Akorn Inc, Hikma, Aurobindo Pharma, Fdc Ltd, Novartis Pharms Corp, Watson Labs Inc, Rising Pharms Inc, Ivax Sub Teva Pharms, Dr Reddys Labs Ltd, Sandoz, Watson Labs, Apotex, Amring Pharms, and Laboratorios Salvat, and is included in thirty-two NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride has forty-five patent family members in seventeen countries.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride. Seventy suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: ciprofloxacin hydrochloride

Tradenames:7
Patents:6
Applicants:29
NDAs:32
Drug Master File Entries: see list31
Suppliers / Packagers: see list70
Bulk Api Vendors: see list49
Clinical Trials: see list2,410
Patent Applications: see list2,039
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ciprofloxacin hydrochloride at DailyMed

Pharmacology for Ingredient: ciprofloxacin hydrochloride

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Tentative approvals for CIPROFLOXACIN HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 250MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 750MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 500MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076136-002Jun 9, 2004DISCNNoNo► Subscribe► Subscribe
Barr
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL074124-001Jun 9, 2004DISCNNoNo► Subscribe► Subscribe
Depomed Inc
PROQUIN XR
ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021744-001May 19, 2005DISCNNoNo5,972,389► SubscribeY ► Subscribe
Pliva
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076426-001Jun 15, 2005DISCNNoNo► Subscribe► Subscribe
Unique Pharm Labs
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076639-003Sep 10, 2004ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare
CIPRO
ciprofloxacin hydrochloride
TABLET;ORAL019537-002Oct 22, 19875,286,754*PED► Subscribe
Novartis Pharms Corp
CILOXAN
ciprofloxacin hydrochloride
SOLUTION/DROPS;OPHTHALMIC019992-001Dec 31, 19904,670,444*PED► Subscribe
Novartis Pharms Corp
CILOXAN
ciprofloxacin hydrochloride
OINTMENT;OPHTHALMIC020369-001Mar 30, 19984,670,444*PED► Subscribe
Bayer Hlthcare
CIPRO
ciprofloxacin hydrochloride
TABLET;ORAL019537-003Oct 22, 19875,286,754*PED► Subscribe
Bayer Hlthcare
CIPRO
ciprofloxacin hydrochloride
TABLET;ORAL019537-004Oct 22, 19874,670,444*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ciprofloxacin hydrochloride

Country Document Number Estimated Expiration
Australia729529► Subscribe
European Patent Office1424069► Subscribe
Austria256455► Subscribe
South Korea20000048500► Subscribe
Japan2000513028► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CIPROFLOXACIN HYDROCHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Chubb
Federal Trade Commission
Cantor Fitzgerald
Boehringer Ingelheim
Teva
Deloitte
Chinese Patent Office
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot